With Mila-Learn, the start-up is using musical exercises to improve care for patients with neurodevelopmental disorders. Dyslexia, dyspraxia or ADD (attention deficit disorders with or without hyperactivity) affect 7 million … Read more
The French company has developed a platform that reveals anomalies in the way cells obtain nutrients, thereby detecting a wide range of diseases, in particular in children. Basing themselves on … Read more
Via its digital service that it offers to hospitals, the young French start-up evaluates and prepares patients before surgery. Today, one in three patients suffers from complications after major … Read more
With Emy, a connected vaginal probe that allows perineal re-education at home, the French start-up is addressing the problems of urinary incontinence and perineal relaxation from which many women suffer. … Read more
The company, founded by two doctors in 2013, is about to launch a tool that allows patients suffering from kidney failure to measure their blood potassium levels from home. Worldwide, … Read more
As part of the overall quality system for the hospitality sector for foreign patients in France developed by the French Healthcare Association, medical concierge companies that are members of the … Read more
The drug developed by Acticor is administered in the first hours of the onset of ischemic stroke symptoms to limit sequelae. Strokes are the second leading cause of death worldwide … Read more
This French biotech company has developed two drug candidates that slow down the degenerative processes associated with aging. Since it was founded fifteen years ago, Biophytis has been focusing its … Read more
Carthera’s medical device facilitates the transfer of blood molecules to the brain through ultrasound. This optimises the efficacy of current treatments. Thanks to its intracranial implant, SonoCloud, Carthera is … Read more
The digital platform developed by Braintale makes accurately assesses brain lesions to optimise neurological treatment. Since spring 2020 Braintale – a spin-off of AP-HP, the Paris hospital authority – has … Read more
With over 30 years of expertise, Généthon has created a complete ecosystem around gene therapies for rare diseases, from research to production. Généthon was created in 1990 by the AFM … Read more
The technology developed by Hemerion Therapeutics is providing great hope for patients with glioblastoma, the most widespread and aggressive brain cancer. In an area where there is currently no cure, … Read more